» Articles » PMID: 16959828

Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease

Overview
Specialty Nephrology
Date 2006 Sep 9
PMID 16959828
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with chronic kidney disease have an increased risk for progression to ESRD. The purpose of this study was to examine factors that predict increased risk for adverse renal outcomes. Cox regression was performed to assess the potential of 38 baseline risk factors to predict the clinical renal composite outcome of 50% or 25-ml/min per 1.73 m(2) GFR decline or ESRD among 1094 black patients with hypertensive nephrosclerosis (GFR 20 to 65 ml/min per 1.73 m(2)). Patients were trial participants who had been randomly assigned to one of two BP goals and to one of three antihypertensive regimens and followed for a range of 3 to 6.4 yr. In unadjusted and adjusted analyses, baseline proteinuria was consistently associated with an increased risk for adverse renal outcomes, even at low levels of proteinuria. The relationship of proteinuria with adverse renal outcomes also was evident in analyses that were stratified by level of GFR, which itself was associated with adverse renal outcomes but only at levels <40 ml/min. Other factors that were significantly associated with increased renal events after adjustment for baseline GFR, age, and gender, both with and without adjustment for baseline proteinuria, included serum creatinine, urea nitrogen, and phosphorus. In black patients with hypertensive nephrosclerosis, increased proteinuria, reduced GFR, and elevated levels of serum creatinine, urea nitrogen and phosphorus were directly associated with adverse clinical renal events. These findings identify a subset of this high-risk population that might benefit from even more aggressive treatment.

Citing Articles

Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease.

Nitta K, Kataoka H, Manabe S, Makabe S, Akihisa T, Ushio Y Clin Exp Nephrol. 2024; 29(1):75-82.

PMID: 39322826 DOI: 10.1007/s10157-024-02568-6.


High Protein Diets and Glomerular Hyperfiltration in Athletes and Bodybuilders: Is Chronic Kidney Disease the Real Finish Line?.

de Lorenzo A, Bomback A, Mihic N Sports Med. 2024; 54(10):2481-2495.

PMID: 39196487 DOI: 10.1007/s40279-024-02086-1.


The association of normal-range serum phosphorus with immunoglobulin A nephropathy progression: a retrospective cohort study.

An X, Ding L, Yang Y, Yang Z, Zhang Y, Bai F Int Urol Nephrol. 2023; 56(1):275-282.

PMID: 37336802 DOI: 10.1007/s11255-023-03678-y.


The Usefulness of Calcium/Magnesium Ratio in the Risk Stratification of Early Onset of Renal Replacement Therapy.

Afonso R, Calcas Marques R, Borges H, Cabrita A, Paula Silva A Diagnostics (Basel). 2022; 12(10).

PMID: 36292159 PMC: 9600033. DOI: 10.3390/diagnostics12102470.


Serum phosphate and chronic kidney and cardiovascular disease: Phosphorus potential implications in general population.

Raikou V World J Nephrol. 2021; 10(5):76-87.

PMID: 34631478 PMC: 8477270. DOI: 10.5527/wjn.v10.i5.76.


References
1.
Chuahirun T, Khanna A, Kimball K, Wesson D . Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Am J Kidney Dis. 2002; 41(1):13-21. DOI: 10.1053/ajkd.2003.50009. View

2.
Miskulin D, Meyer K, Martin A, Fink N, Coresh J, Powe N . Comorbidity and its change predict survival in incident dialysis patients. Am J Kidney Dis. 2002; 41(1):149-61. DOI: 10.1053/ajkd.2003.50034. View

3.
Post W, Hill M, Dennison C, Weiss J, Gerstenblith G, Blumenthal R . High prevalence of target organ damage in young, African American inner-city men with hypertension. J Clin Hypertens (Greenwich). 2003; 5(1):24-30. PMC: 8101811. DOI: 10.1111/j.1524-6175.2003.01246.x. View

4.
Kalantar-Zadeh K, Block G, Humphreys M, Kopple J . Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003; 63(3):793-808. DOI: 10.1046/j.1523-1755.2003.00803.x. View

5.
Keane W, Brenner B, de Zeeuw D, Grunfeld J, McGill J, Mitch W . The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 2003; 63(4):1499-507. DOI: 10.1046/j.1523-1755.2003.00885.x. View